WO2000069415A3 - Melt granulation - Google Patents
Melt granulation Download PDFInfo
- Publication number
- WO2000069415A3 WO2000069415A3 PCT/SI2000/000013 SI0000013W WO0069415A3 WO 2000069415 A3 WO2000069415 A3 WO 2000069415A3 SI 0000013 W SI0000013 W SI 0000013W WO 0069415 A3 WO0069415 A3 WO 0069415A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- melt granulation
- bitterness
- diabetics
- patient
- site
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Liquid Deposition Of Substances Of Which Semiconductor Devices Are Composed (AREA)
- Glanulating (AREA)
- Crystals, And After-Treatments Of Crystals (AREA)
Abstract
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL00351654A PL351654A1 (en) | 1999-05-19 | 2000-05-18 | Melt granulation |
EP00931886A EP1183013A2 (en) | 1999-05-19 | 2000-05-18 | Melt granulation |
SK1664-2001A SK16642001A3 (en) | 1999-05-19 | 2000-05-18 | Pharmaceutical formulation in granular form |
AU49697/00A AU4969700A (en) | 1999-05-19 | 2000-05-18 | Melt granulation |
EEP200100607A EE200100607A (en) | 1999-05-19 | 2000-05-18 | Pharmaceutical composition in granular form and a process for its preparation |
HR20010932A HRP20010932A2 (en) | 1999-05-19 | 2001-12-18 | Melt granulation |
BG106236A BG106236A (en) | 1999-05-19 | 2001-12-19 | Melt granulation |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SI9900119A SI20244A (en) | 1999-05-19 | 1999-05-19 | Melt granulation |
SIP-9900119 | 1999-05-19 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000069415A2 WO2000069415A2 (en) | 2000-11-23 |
WO2000069415A3 true WO2000069415A3 (en) | 2001-04-26 |
Family
ID=20432471
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/SI2000/000013 WO2000069415A2 (en) | 1999-05-19 | 2000-05-18 | Melt granulation |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1183013A2 (en) |
AU (1) | AU4969700A (en) |
BG (1) | BG106236A (en) |
CZ (1) | CZ20014133A3 (en) |
EE (1) | EE200100607A (en) |
HR (1) | HRP20010932A2 (en) |
HU (1) | HUP0201233A3 (en) |
PL (1) | PL351654A1 (en) |
RU (1) | RU2001134166A (en) |
SI (1) | SI20244A (en) |
SK (1) | SK16642001A3 (en) |
WO (1) | WO2000069415A2 (en) |
YU (1) | YU82001A (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK1267840T3 (en) * | 2000-03-28 | 2009-09-07 | Sandoz Ag | Granulated particles with masked taste |
MXPA03003146A (en) * | 2000-10-13 | 2004-12-06 | Advancis Pharmaceuticals | Extended release erythromycin derivatives. |
AU2003211243B8 (en) | 2002-02-21 | 2008-11-06 | Otsuka Pharmaceutical Co., Ltd. | Sustained release preparations and process for producing the same |
US7943585B2 (en) | 2003-12-22 | 2011-05-17 | Sandoz, Inc. | Extended release antibiotic composition |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991019486A1 (en) * | 1990-06-14 | 1991-12-26 | Kalmo Enterprises, Inc. | Stable aqueous drug suspensions |
WO1993017667A1 (en) * | 1992-03-12 | 1993-09-16 | Taisho Pharmaceutical Co., Ltd. | Composition for oral preparations |
WO1994012157A1 (en) * | 1992-11-30 | 1994-06-09 | Kv Pharmaceutical Company | Tastemasked pharmaceutical materials |
WO2000061119A2 (en) * | 1999-04-09 | 2000-10-19 | Pharmaplus S.R.L. | A process for the microencapsulation of medicaments |
-
1999
- 1999-05-19 SI SI9900119A patent/SI20244A/en not_active IP Right Cessation
-
2000
- 2000-05-18 WO PCT/SI2000/000013 patent/WO2000069415A2/en not_active Application Discontinuation
- 2000-05-18 PL PL00351654A patent/PL351654A1/en not_active Application Discontinuation
- 2000-05-18 CZ CZ20014133A patent/CZ20014133A3/en unknown
- 2000-05-18 SK SK1664-2001A patent/SK16642001A3/en unknown
- 2000-05-18 AU AU49697/00A patent/AU4969700A/en not_active Abandoned
- 2000-05-18 RU RU2001134166/14A patent/RU2001134166A/en not_active Application Discontinuation
- 2000-05-18 EE EEP200100607A patent/EE200100607A/en unknown
- 2000-05-18 HU HU0201233A patent/HUP0201233A3/en unknown
- 2000-05-18 YU YU82001A patent/YU82001A/en unknown
- 2000-05-18 EP EP00931886A patent/EP1183013A2/en not_active Withdrawn
-
2001
- 2001-12-18 HR HR20010932A patent/HRP20010932A2/en not_active Application Discontinuation
- 2001-12-19 BG BG106236A patent/BG106236A/en unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1991019486A1 (en) * | 1990-06-14 | 1991-12-26 | Kalmo Enterprises, Inc. | Stable aqueous drug suspensions |
WO1993017667A1 (en) * | 1992-03-12 | 1993-09-16 | Taisho Pharmaceutical Co., Ltd. | Composition for oral preparations |
US5707646A (en) * | 1992-03-12 | 1998-01-13 | Taisho Pharmaceutical Co., Ltd. | Taste masking pharmaceutical composition |
WO1994012157A1 (en) * | 1992-11-30 | 1994-06-09 | Kv Pharmaceutical Company | Tastemasked pharmaceutical materials |
WO2000061119A2 (en) * | 1999-04-09 | 2000-10-19 | Pharmaplus S.R.L. | A process for the microencapsulation of medicaments |
Non-Patent Citations (2)
Title |
---|
S. EL-SHANAWANY: "Sustained release of nitrofurantoin frominert wax matrixes", JOURNAL OF CONTROLLED RELEASE, vol. 26, no. 1, 1 July 1993 (1993-07-01), Amsterdam (NL), pages 11 - 19, XP000377735 * |
S. ZGOULLI ET AL.: "Microencapsulation of erythromycin and clarithromycin using a spray-drying technique", JOURNAL OF MICROENCAPSULATION, vol. 16, no. 5, September 1999 (1999-09-01), London (GB), pages 565 - 571, XP000834849 * |
Also Published As
Publication number | Publication date |
---|---|
WO2000069415A2 (en) | 2000-11-23 |
SI20244A (en) | 2000-12-31 |
EE200100607A (en) | 2003-02-17 |
SK16642001A3 (en) | 2002-05-09 |
HUP0201233A3 (en) | 2003-10-28 |
YU82001A (en) | 2004-07-15 |
CZ20014133A3 (en) | 2002-03-13 |
BG106236A (en) | 2002-08-30 |
AU4969700A (en) | 2000-12-05 |
HRP20010932A2 (en) | 2003-04-30 |
RU2001134166A (en) | 2003-08-27 |
EP1183013A2 (en) | 2002-03-06 |
PL351654A1 (en) | 2003-05-19 |
HUP0201233A2 (en) | 2002-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1040823A3 (en) | Stable foam compositions | |
WO2001041737A3 (en) | Solid oral dosage form | |
IL138969A0 (en) | Anthranilic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
MY129350A (en) | Aripiprazole oral solution | |
WO2001026693A3 (en) | Manufacture of polyglutamate-therapeutic agent conjugates | |
HUP0204170A3 (en) | 5-thia-omega-substituted phenyl-prostaglandin e derivatives, process for producing the same and drugs containing the same as the active ingredient | |
WO2001076575A3 (en) | The treatment of respiratory diseases | |
EE04850B1 (en) | Use of pyrimidine derivatives for the preparation of a medicament for the treatment of HIV infection, a compound, a pharmaceutical composition containing it, a process for the preparation of a compound and a composition, and a combination preparation for use in the treatment of HIV infection. | |
HK1067626A1 (en) | Novel 2h-pyridazine-3-one derivatives, pharmaceutical compositions containing the same and a process for the preparation of the active ingredient | |
HK1041814A1 (en) | Drug delivery device, especially for the delivery of progestins and estrogens. | |
IL140897A0 (en) | Benzocycloheptene derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
WO2001041742A3 (en) | Antiviral medication | |
AU2002238855A1 (en) | N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same | |
HUP0400155A3 (en) | N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same | |
IL154096A0 (en) | Aporphine derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
DE60042972D1 (en) | Delayed-release drug-containing trimetazidine and method of preparation | |
HK1015789A1 (en) | Propanolamine derivatives, processes for their preparation, pharmaceuticals comprising these compounds, and their use. | |
HUP0204202A3 (en) | Ibuprofen containing active agent preparation, process for its preparation and pharmaceutical compositions containing it | |
AU2001234107A1 (en) | Benzoic acid derivatives, process for producing the same and drugs containing the same as the active ingredient | |
WO2000069415A3 (en) | Melt granulation | |
WO2002049607A3 (en) | Flavoured oral drug delivery system | |
WO2003041656A3 (en) | Soluble drug extended release system | |
WO2002034240A3 (en) | Delayed and sustained release formulations and method of use thereof | |
MX9709453A (en) | Oral pharmaceutical composition of piperidinoalkanol compounds in solution form. | |
HK1041000B (en) | Novel pyrimidine derivatives and processes for the preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: P-820/01 Country of ref document: YU |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
WWE | Wipo information: entry into national phase |
Ref document number: 16642001 Country of ref document: SK |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2001-4133 Country of ref document: CZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: P20010932A Country of ref document: HR Ref document number: 2000931886 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2000 106236 Country of ref document: BG Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 2000931886 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: PV2001-4133 Country of ref document: CZ |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2000931886 Country of ref document: EP |